Jeremy Davis
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeremy Davis
Standard Biotools Inc. reported in an 8-K filed January 10, 2025 that Jeremy Davis was terminated as Chief Commercial Officer, effective February 1, 2025. The proxy statement of Standard Biotools Inc. reports total compensation of $1,404,172 for Jeremy Davis in fiscal 2022, including a base salary of $298,485.
“On January 3, 2025, Standard BioTools Inc. (the “Company”) and Jeremy Davis, the Company’s Chief Commercial Officer, mutually determined that Mr. Davis will no longer serve in such position, effective as of February 1, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Standard Biotools Inc. (LAB)
Proxy statement
Start not stated–2025-02-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Standard Biotools Inc. (LAB) | Chief Commercial Officer | $298,485 | $1,404,172 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.